Cargando…
Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
Chronic prurigo (CPG) is a chronic inflammatory disease characterized by intense pruritus, and therapy is often challenging due to its unclear pathogenesis. Here, we report four patients with refractory CPG from different backgrounds who experienced failure of conventional therapy and were controlle...
Autores principales: | Luo, Nana, Wang, Qiuyue, Lei, Min, Li, Tianhao, Hao, Pingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480179/ https://www.ncbi.nlm.nih.gov/pubmed/36117770 http://dx.doi.org/10.2147/CCID.S379231 |
Ejemplares similares
-
Burning and Scaling Probably Associated with Dupilumab Therapy: A Case Report
por: Luo, Nana, et al.
Publicado: (2022) -
Tofacitinib for Prurigo Nodularis: A Case Report
por: Peng, Changlan, et al.
Publicado: (2022) -
Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life
por: Richter, Clara, et al.
Publicado: (2023) -
Recalcitrant prurigo nodularis treated successfully with dupilumab
por: Rambhia, Pooja H., et al.
Publicado: (2019) -
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
por: Wieser, Jill K, et al.
Publicado: (2020)